Dorenbaum Alejandro 4
4 · Reneo Pharmaceuticals, Inc. · Filed Dec 14, 2021
Insider Transaction Report
Form 4
Dorenbaum Alejandro
Chief Medical Officer
Transactions
- Award
Common Stock
2021-12-10+30,000→ 52,348 total - Award
Stock option (right to buy)
2021-12-10+100,000→ 100,000 totalExercise: $6.69Exp: 2031-12-09→ Common Stock (100,000 underlying)
Footnotes (2)
- [F1]Represents a restricted stock unit award.
- [F2]The shares vest in a series of 48 successive equal monthly installments measured from December 10, 2021, subject to Reporting Persons's Continuous Service (as defined in the Issuer's 2021 Equity Incentive Plan) as of each such vesting date.